DocMorris

DocMorris Stock-Based Compensation

The Stock-Based Compensation (SBC) of DocMorris (DOCM.SW) as of Nov 19, 2026 is 3.93 M CHF. In the previous year, Stock-Based Compensation (SBC) was 3.70 M CHF — a change of 6.18% (higher).

Stock-Based Compensation

3.93 MCHF

YoY

6.18%

Last updated:

Stock-Based Compensation (SBC) of DocMorris is 2023 3.93 M CHF. Stock-Based Compensation (SBC) of DocMorris was 2022 3.70 M CHF. It decreases by 6.18% higher compared to the previous year.

The DocMorris Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2016
1.59 M CHF
Jan 1, 2017
3.24 M CHF
Jan 1, 2018
1.99 M CHF
Jan 1, 2019
3.87 M CHF
Jan 1, 2020
17.14 M CHF
Jan 1, 2021
8.57 M CHF
Jan 1, 2022
3.70 M CHF
Jan 1, 2023
3.93 M CHF
The DocMorris Stock-Based Compensation history
YEARStock-Based CompensationYoY
3.93 MCHF+6.18%
3.70 MCHF-56.77%
8.57 MCHF-50.03%
17.14 MCHF+342.67%
3.87 MCHF+94.96%
1.99 MCHF-38.67%
3.24 MCHF+103.26%
1.59 MCHF+1,144.53%
128,000.00CHF-74.19%
496,000.00CHF—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DocMorris Stock analysis

What does DocMorris do? The Zur Rose Group AG is a Swiss company that specializes in online trading of medications and health products. The company was founded in 1993 in Steckborn and initially focused on the mail order of homeopathic medicines. In 1997, the online shop www.zurrose.de was opened and the company began to expand its distribution to non-homeopathic medicines. The business model of the Zur Rose Group AG is based on a three-pillar model, encompassing e-commerce, wholesale, and healthcare. In the e-commerce sector, the company operates online pharmacies in various countries including Germany, France, Austria, the Netherlands, and Switzerland. In the wholesale sector, the company supplies pharmacies and hospitals with medicines and medical products. In the healthcare sector, the company offers various services in healthcare, from the production of medicines to the processing of prescriptions. The Zur Rose Group AG offers a wide range of products and services including prescription and over-the-counter medications, natural remedies, cosmetic products, dietary supplements, and medical devices. The company aims to provide its customers with a comprehensive selection of high-quality products and works closely with its suppliers to ensure that all products meet the highest quality standards. In the e-commerce sector, the company operates various online pharmacies, including Zur Rose Apotheke in Germany, Zur Rose Apotheke in Austria, and Doctipharma in France. These online pharmacies offer a wide range of medications and health products that can be ordered online and conveniently delivered to customers' homes. The online pharmacies are open 24/7, allowing customers to quickly and easily order their needed medications. In the wholesale sector, the company offers a wide range of pharmaceutical products and medical devices to pharmacies and hospitals. The company works closely with its suppliers to ensure that all products meet the highest quality standards. Additionally, the company also provides a fast and reliable delivery service to ensure that its customers are always provided with the needed medications and medical products. In the healthcare sector, the company offers various services in healthcare, including digitalization solutions for pharmacies, manufacturing of medications, and processing of prescriptions. The company works closely with its customers to offer tailored solutions that meet their individual requirements. Over the years, the Zur Rose Group AG has become a leading provider in the online trading of medications and health products. The company has distinguished itself through its wide product range, fast and reliable delivery service, and excellent customer service. Additionally, the company has also invested in the development of new technologies to ensure that it can always offer its customers the best products and services. Overall, the Zur Rose Group AG is an innovative company built on a long history in healthcare. The company strives to offer its customers a wide range of high-quality products and services and has established itself as a leading provider in the online trading of medications and health products. DocMorris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DocMorris stock

Stock-Based Compensation (SBC) of DocMorris is 3.93 M CHF in 2023.

Stock-Based Compensation (SBC) of DocMorris changed from 3.70 M CHF to 3.93 M CHF, representing a 6.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) DocMorris since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s CHF is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s DocMorris historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — DocMorris

All Key Metrics — DocMorris